| Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome–positive chronic myelogenous leukemia … HM Kantarjian, F Giles, N Gattermann, K Bhalla, G Alimena, F Palandri, ... Blood, The Journal of the American Society of Hematology 110 (10), 3540-3546, 2007 | 962 | 2007 |
| Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment R Bhatia, M Holtz, N Niu, R Gray, DS Snyder, CL Sawyers, DA Arber, ... Blood 101 (12), 4701-4707, 2003 | 732 | 2003 |
| miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts AM Eiring, JG Harb, P Neviani, C Garton, JJ Oaks, R Spizzo, S Liu, ... Cell 140 (5), 652-665, 2010 | 699 | 2010 |
| Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival A Hamilton, GV Helgason, M Schemionek, B Zhang, S Myssina, EK Allan, ... Blood, The Journal of the American Society of Hematology 119 (6), 1501-1510, 2012 | 487 | 2012 |
| PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia Z Gu, ML Churchman, KG Roberts, I Moore, X Zhou, J Nakitandwe, ... Nature genetics 51 (2), 296-307, 2019 | 460 | 2019 |
| Activation of p53 by SIRT1 inhibition enhances elimination of CML leukemia stem cells in combination with imatinib L Li, L Wang, L Li, Z Wang, Y Ho, T McDonald, TL Holyoake, WY Chen, ... Cancer cell 21 (2), 266-281, 2012 | 449 | 2012 |
| High frequency and poor outcome of Philadelphia chromosome–like acute lymphoblastic leukemia in adults KG Roberts, Z Gu, D Payne-Turner, K McCastlain, RC Harvey, IM Chen, ... Journal of Clinical Oncology 35 (4), 394, 2017 | 427 | 2017 |
| T cells expressing CD123-specific chimeric antigen receptors exhibit specific cytolytic effector functions and antitumor effects against human acute myeloid leukemia A Mardiros, C Dos Santos, T McDonald, CE Brown, X Wang, LE Budde, ... Blood, The Journal of the American Society of Hematology 122 (18), 3138-3148, 2013 | 422 | 2013 |
| Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion B Kumar, M Garcia, L Weng, X Jung, JL Murakami, X Hu, T McDonald, ... Leukemia 32 (3), 575-587, 2018 | 407 | 2018 |
| Altered microenvironmental regulation of leukemic and normal stem cells in chronic myelogenous leukemia B Zhang, YW Ho, Q Huang, T Maeda, A Lin, S Lee, A Hair, TL Holyoake, ... Cancer cell 21 (4), 577-592, 2012 | 403 | 2012 |
| Clonal hematopoiesis associated with adverse outcomes after autologous stem-cell transplantation for lymphoma CJ Gibson, RC Lindsley, V Tchekmedyian, BG Mar, J Shi, S Jaiswal, ... Journal of Clinical Oncology 35 (14), 1598, 2017 | 399 | 2017 |
| Stem cell quiescence L Li, R Bhatia Clinical cancer research 17 (15), 4936-4941, 2011 | 379 | 2011 |
| Solid cancers after bone marrow transplantation S Bhatia, AD Louie, R Bhatia, MR O’Donnell, H Fung, A Kashyap, ... Journal of Clinical Oncology 19 (2), 464-471, 2001 | 357 | 2001 |
| Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors A Krishnan, S Bhatia, ML Slovak, DA Arber, JC Niland, A Nademanee, ... Blood, The Journal of the American Society of Hematology 95 (5), 1588-1593, 2000 | 340 | 2000 |
| Imatinib mesylate (STI571) inhibits growth of primitive malignant progenitors in chronic myelogenous leukemia through reversal of abnormally increased proliferation MS Holtz, ML Slovak, F Zhang, CL Sawyers, SJ Forman, R Bhatia Blood, The Journal of the American Society of Hematology 99 (10), 3792-3800, 2002 | 332 | 2002 |
| Microenvironmental protection of CML stem and progenitor cells from tyrosine kinase inhibitors through N-cadherin and Wnt–β-catenin signaling B Zhang, M Li, T McDonald, TL Holyoake, RT Moon, D Campana, L Shultz, ... Blood, The Journal of the American Society of Hematology 121 (10), 1824-1838, 2013 | 312 | 2013 |
| Effective targeting of quiescent chronic myelogenous leukemia stem cells by histone deacetylase inhibitors in combination with imatinib mesylate B Zhang, AC Strauss, S Chu, M Li, Y Ho, KD Shiang, DS Snyder, ... Cancer cell 17 (5), 427-442, 2010 | 307 | 2010 |
| Persistence of leukemia stem cells in chronic myelogenous leukemia patients in prolonged remission with imatinib treatment S Chu, T McDonald, A Lin, S Chakraborty, Q Huang, DS Snyder, R Bhatia Blood, The Journal of the American Society of Hematology 118 (20), 5565-5572, 2011 | 303 | 2011 |
| Detection of BCR-ABL kinase mutations in CD34+ cells from chronic myelogenous leukemia patients in complete cytogenetic remission on imatinib mesylate … S Chu, H Xu, NP Shah, DS Snyder, SJ Forman, CL Sawyers, R Bhatia Blood 105 (5), 2093-2098, 2005 | 271 | 2005 |
| Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia Z Gu, M Churchman, K Roberts, Y Li, Y Liu, RC Harvey, K McCastlain, ... Nature communications 7 (1), 13331, 2016 | 266 | 2016 |
